top of page

Thu, Jun 08

|

Virtual Event via Zoom

FDA Oncology Center of Excellence Presents

FDA Listening Session "Drug Development in Molecular Subsets of Non-Small Cell Lung Cancer – Challenges and Opportunities from a Patient Perspective”

Registration is closed
See other events

Time & Location

Jun 08, 2023, 2:30 PM – 4:00 PM

Virtual Event via Zoom

About the Event

Register now to join FDA and the representatives from the following patient advocacy groups: 

ALK Fusion; ALK Positive, BRAF Bombers, EGFR Resisters, Exon 20 Group at ICAN, KRAS Kickers, MET Crusaders, NTRKers, RET Renegades and the ROS1ders

Discussion topics includes:

  • Targeted Therapy Clinical Trials
  • Survivorship and Quality of Life
  • Biomarker Testing

Date: June 8, 2023, 2:30-4:00 pm, ET

Coordinators: Drs. Luckson Mathieu, Satinder (Mona) Choudhary, and Harpreet Singh 

After registering, you will receive a confirmation email containing the link and information to join the webinar on June 8th.

Register:

https://fda.zoomgov.com/webinar/register/WN_I7xkiO9cRKKl1MA7AwHjUA

Share This Event

bottom of page